-+ 0.00%
-+ 0.00%
-+ 0.00%

Ikonisys H1 2026 Net Loss Narrows 17% to EUR 847,773; H1 2026 Revenue Falls 18% to EUR 623,823

PUBT·10/31/2026 14:08:41
Listen to the news
Ikonisys H1 2026 Net Loss Narrows 17% to EUR 847,773; H1 2026 Revenue Falls 18% to EUR 623,823
  • Ikonisys, renamed Aliko Scientific, narrowed its first-half 2026 consolidated net loss 17% year over year to EUR 847,773.
  • Revenue fell 18% year over year to EUR 623,823, with a smaller contribution from a one-off Ethiopian hospital IT project.
  • Cash and cash equivalents dropped 50% to EUR 514,399 at June 30, 2026, from December 31, 2025.
  • A September 21 settlement ended litigation involving its US subsidiary and provides for a USD 2 million payment to that subsidiary.
  • Distribution agreements announced August 5 in Romania and Saudi Arabia carry minimum purchase commitments totaling EUR 3.97 million over five years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ikonisys SA published the original content used to generate this news brief on October 31, 2026, and is solely responsible for the information contained therein.